Sciatica Treatment Market Size, Share, Growth Analysis, By Drug class(Non-steroidal anti-inflammatory drugs, Steroids, Antidepressants and Others), By Type(Acute sciatica, Chronic sciatica, and Others), By Distribution channel(Hospital pharmacies, Retail & specialty pharmacies, and Online providers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2822 | Region: Global | Published Date: July, 2024
Pages: 219 |Tables: 90 |Figures: 72

Sciatica Treatment Market Insights

Global Sciatica Treatment Market size was valued at USD 705.80 million in 2022 and is poised to grow from USD 734.74 million in 2023 to USD 1013.30 million by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

Sciatica is a condition characterized by the radiating pain along the path of the sciatic nerve, extending from the lower back through the hips and down each leg. This discomfort often arises when factors such as a herniated disk, spinal bone spur, or spinal stenosis compress a part of the sciatic nerve, triggering inflammation and causing symptoms such as pain, numbness, tingling, or weakness in the affected leg. The prevalence of sciatica has observed a notable increase in recent years, driven by various contributing factors.  

Sedentary lifestyles, a heightened prevalence of obesity, and an aging population have played significant roles in the surge of sciatica cases. Additionally, advancements in diagnostic technologies have enhanced the accuracy of sciatica diagnosis, leading to a greater number of reported instances. According to a study by MMR, approximately 40% of individuals experience sciatica at some point in their lives, with a higher occurrence during the 40s and 50s, and a more frequent impact on men compared to women.

Market Snapshot - 2024-2031

Global Market Size

USD 705.80 billion

Largest Segment

Non-steroidal anti-inflammatory drugs

Fastest Growth

Steroids

Growth Rate

4.1% CAGR

Sciatica Treatment Market ($ Mn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Sciatica Treatment Market Segmental Analysis

Global Sciatica Treatment Market is segmented based on drug class, type, distribution channel, and region. Based on drug class, the market is segmented into Non-steroidal Anti-inflammatory Drugs, Steroids, Antidepressants, and Others. Based on type, the market is segmented into Acute sciatica, Chronic Sciatica, and Others. Based on distribution channel, the market is segmented into Hospital pharmacies, Retail & specialty pharmacies, and Online providers. Based on region, the market is segmented into North America, Europe, Asia pacific, Latin America, and Middle East & Africa. 

Analysis by Drug Class 

In 2023, the non-steroidal anti-inflammatory drug (NSAID) segment secured the largest revenue share, accounting for 39.47% and asserting dominance in the global sciatica treatment market. This segment is poised to continue its leading position, with an anticipated Compound Annual Growth Rate (CAGR) of 3.12% during the forecast period, maintaining its stronghold by 2029. NSAIDs, renowned for their efficacy, represent a popular treatment choice for sciatica.  

The steroids segment is poised for substantial growth, with an anticipated significant Compound Annual Growth Rate (CAGR) during the forecast period, securing the second-highest position in the global sciatica treatment market. Steroids, especially corticosteroids, are extensively prescribed for treating sciatica owing to their potent anti-inflammatory properties. This characteristic is expected to be a key driver for the segment's growth. 

Analysis by Distribution Channel 

The online providers segment plays a crucial role in the sciatica treatment market by offering a digital avenue for information dissemination, consultation, and access to relevant products. In the contemporary healthcare landscape, online platforms serve as valuable resources for individuals seeking information on sciatica symptoms, treatment options, and preventive measures. These providers facilitate virtual consultations, enabling patients to connect with healthcare professionals remotely. 

The hospital pharmacies segment played a significant role in contributing to the substantial revenue share within the sciatica treatment market in 2022. Projections for the upcoming period suggest a continued growth trajectory for this category. The dominance of hospitals in this industry is attributed to their role in managing a diverse range of patients exhibiting symptoms of sciatica.

Sciatica Treatment Market By Drug Class

To get detailed analysis on other segments, Request For Free Sample Report

Sciatica Treatment Market Regional Insights

North America is anticipated to exhibit significant growth, with a projected Compound Annual Growth Rate (CAGR) of 15.6% during the forecast period in 2023. This robust growth is attributed to the high prevalence of sciatica in North America, supported by the region's advanced healthcare infrastructure and favorable reimbursement policies. These factors collectively contribute to the expanding market for sciatica treatment in North America. Notably, non-steroidal anti-inflammatory drugs (NSAIDs) represent a commonly prescribed segment for sciatica treatment, known for its accessibility over the counter.

The market in the Asia-Pacific is poised for substantial growth, projected to register a Compound Annual Growth Rate (CAGR) of 5.8% in 2023. This forecast presents lucrative opportunities for participants in the sciatica treatment market throughout the forecast period. Key factors contributing to this anticipated growth include the expanding aging population, heightened awareness and diagnosis of sciatica, and the ongoing enhancement of healthcare infrastructure in emerging economies within the region.

Sciatica Treatment Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Sciatica Treatment Market Dynamics

Drivers

Increasing Incidence of Chronic Sciatica Among Population 

  • Sciatica is a prevalent condition with a lifetime occurrence rate reaching up to 43%, affecting approximately 10-40% of the population, with higher rates observed in older age groups. The increasing incidence of both chronic and acute sciatica among individuals serves as a significant driver propelling the growth of the Sciatica Treatment Market. According to the MMR Study, sciatica exerts its impact on a substantial percentage of the population, ranging from 10-40%, with a more pronounced prevalence in older age brackets. Notably, adults aged 20-59 display a prevalence of 13.1%, while individuals aged 60 and above experience a higher rate of 19.2%, underscoring the heightened impact within older demographics. 

Restraints 

High Cost of Certain Treatments 

  • Surgical procedures like microdiscectomy or spinal fusion, often recommended for sciatica, come with substantial costs. Additionally, emerging treatments such as stem cell therapy, while promising, entail higher expenses, and there's a possibility that insurance coverage may not extend to these procedures. The elevated costs associated with these treatments pose a significant barrier, limiting access to certain therapeutic options, particularly for patients in low- and middle-income countries where healthcare resources are already constrained. 

Request Free Customization of this report to help us to meet your business objectives.

Sciatica Treatment Market Competitive Landscape

The competitive environment of the global Sciatica Treatment market  is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 

Top Player’s Company Profiles

  • Pfizer Inc. (United States) 
  • Johnson & Johnson (United States) 
  • Teva Pharmaceutical Industries Ltd. (Israel) 
  • Novartis AG (Switzerland) 
  • AstraZeneca PLC (United Kingdom) 
  • Merck & Co., Inc. (United States) 
  • Eli Lilly and Company (United States) 
  • GlaxoSmithKline plc (United Kingdom) 
  • Sanofi S.A. (France) 
  • Bayer AG (Germany) 
  • Boehringer Ingelheim International GmbH (Germany) 
  • AbbVie Inc. (United States) 
  • Bristol Myers Squibb (United States) 
  • Amgen Inc. (United States) 
  • Biogen Inc. (United States) 
  • Allergan plc (Ireland) 
  • Roche Holding AG (Switzerland) 
  • Takeda Pharmaceutical Company Limited (Japan) 
  • Mylan N.V. (Netherlands) 
  • Gilead Sciences, Inc. (United States)

Recent Developments

  • In March 2022, Sorrento Therapeutics, Inc. will have 100,000 shares. (NASDAQ:SRN) becomes the largest company in the world. The trial demonstrated the efficacy and safety of SP-102, with sustained pain relief demonstrated over 12 weeks.
  • In December 2021, the United States Food and Drug Administration (FDA) granted Fast Track designation for SP-102, primarily injectable dexamethasone sodium phosphate viscous gel formulation. This designation confirms FDA's demonstrated efficacy of SP-102, regulatory review system, emphasizing the importance of this new treatment modality in the treatment of sciatica.

Sciatica Treatment Key Market Trends

  • The field of sciatica treatment has witnessed a transformative impact from advancements in diagnostic imaging technologies, specifically MRI and CT scans. These technological innovations have revolutionized the identification of the underlying causes of sciatica, enabling swifter and more accurate diagnoses and facilitating prompt interventions. Early diagnosis is crucial in preventing the progression of sciatica into chronic and debilitating conditions. The heightened precision in diagnostics, thanks to advanced imaging technologies, positively influences the treatment landscape by empowering healthcare professionals to intervene promptly and effectively. This not only improves patient outcomes but also prevents the chronicity of the condition and associated disabilities. Consequently, the escalating incidence of sciatica serves as a significant driver propelling the growth of the Sciatica Treatment Market.

Sciatica Treatment Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The escalating prevalence of sciatica is a significant driver propelling the demand for advanced therapies, thereby fostering the growth of the sciatica treatment market. Furthermore, the continuous evolution of treatment options through technological advancements, coupled with the increasing healthcare expenditure globally, contributes to the positive trajectory of the sciatica treatment industry. The industry is witnessing a shift towards the development of minimally invasive procedures, reflecting a commitment to enhancing patient outcomes and reducing the invasiveness of treatments. The surge in research and development activities focused on discovering more effective and less invasive treatment modalities to address the diverse needs of patients is expected to further amplify the sciatica treatment market size during the forecast period.

Report Metric Details
Market size value in 2022 USD 705.80 million
Market size value in 2031 USD 1013.30 million
Growth Rate 4.1%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Drug class
    • Non-steroidal anti-inflammatory drugs, Steroids, Antidepressants and Others
  • Type
    • Acute sciatica, Chronic sciatica, and Others
  • Distribution channel
    • Hospital pharmacies, Retail & specialty pharmacies, and Online providers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer Inc. (United States) 
  • Johnson & Johnson (United States) 
  • Teva Pharmaceutical Industries Ltd. (Israel) 
  • Novartis AG (Switzerland) 
  • AstraZeneca PLC (United Kingdom) 
  • Merck & Co., Inc. (United States) 
  • Eli Lilly and Company (United States) 
  • GlaxoSmithKline plc (United Kingdom) 
  • Sanofi S.A. (France) 
  • Bayer AG (Germany) 
  • Boehringer Ingelheim International GmbH (Germany) 
  • AbbVie Inc. (United States) 
  • Bristol Myers Squibb (United States) 
  • Amgen Inc. (United States) 
  • Biogen Inc. (United States) 
  • Allergan plc (Ireland) 
  • Roche Holding AG (Switzerland) 
  • Takeda Pharmaceutical Company Limited (Japan) 
  • Mylan N.V. (Netherlands) 
  • Gilead Sciences, Inc. (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Sciatica Treatment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Sciatica Treatment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Sciatica Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sciatica Treatment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sciatica Treatment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Sciatica Treatment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Sciatica Treatment Market size was valued at USD 705.80 million in 2022 and is poised to grow from USD 734.74 million in 2023 to USD 1013.30 million by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

The competitive environment of the global Sciatica Treatment market  is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.  'Pfizer Inc. (United States) ', 'Johnson & Johnson (United States) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Novartis AG (Switzerland) ', 'AstraZeneca PLC (United Kingdom) ', 'Merck & Co., Inc. (United States) ', 'Eli Lilly and Company (United States) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Sanofi S.A. (France) ', 'Bayer AG (Germany) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'AbbVie Inc. (United States) ', 'Bristol Myers Squibb (United States) ', 'Amgen Inc. (United States) ', 'Biogen Inc. (United States) ', 'Allergan plc (Ireland) ', 'Roche Holding AG (Switzerland) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Mylan N.V. (Netherlands) ', 'Gilead Sciences, Inc. (United States)'

The field of sciatica treatment has witnessed a transformative impact from advancements in diagnostic imaging technologies, specifically MRI and CT scans. These technological innovations have revolutionized the identification of the underlying causes of sciatica, enabling swifter and more accurate diagnoses and facilitating prompt interventions. Early diagnosis is crucial in preventing the progression of sciatica into chronic and debilitating conditions. The heightened precision in diagnostics, thanks to advanced imaging technologies, positively influences the treatment landscape by empowering healthcare professionals to intervene promptly and effectively. This not only improves patient outcomes but also prevents the chronicity of the condition and associated disabilities. Consequently, the escalating incidence of sciatica serves as a significant driver propelling the growth of the Sciatica Treatment Market.

North America is anticipated to exhibit significant growth, with a projected Compound Annual Growth Rate (CAGR) of 15.6% during the forecast period in 2023. This robust growth is attributed to the high prevalence of sciatica in North America, supported by the region's advanced healthcare infrastructure and favorable reimbursement policies. These factors collectively contribute to the expanding market for sciatica treatment in North America. Notably, non-steroidal anti-inflammatory drugs (NSAIDs) represent a commonly prescribed segment for sciatica treatment, known for its accessibility over the counter.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Sciatica Treatment Market

Report ID: SQMIG35A2822

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE